Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adenocarcinoma
Research on adenocarcinoma reported by scientists at University of Amsterdam, Department of Surgery
May 4th, 2008
Current study results from the report, '18FDG uptake in oesophageal adenocarcinoma: linking biology and outcome,' have been published. According to recent research published in the Journal of Cancer Research and Clinical Oncology, "Variable uptake of 18FDG has been noticed in positron emission tomography (PET) studies of patients with oesophageal adenocarcinoma. The aim of the present study was to investigate biological parameters involved in 18FDG uptake in oesophageal adenocarcinoma for selection of patients with increased 18FDG uptake and prediction of prognostic value of 18FDG PET." "Preoperative PET scans were performed in 26 patients with histologically...
Source: Pharma Investments, Ventures & Law Weekly (2008-05-04)
|
